Search

everythinglearnresearchcommunity

for

Search:↓

The hair serum reduced hair loss and improved hair quality in women.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

COVID-19 infection is highly related to increased hair loss, especially in women.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

COVID-19 can cause temporary hair loss.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

COVID-19 can cause a temporary hair loss condition.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.